First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301). [PDF]
Stambler BS+15 more
europepmc +1 more source
A challenging and rare ablation of both epicardial and endocardial accessory pathway in a patient with paroxysmal supraventricular tachycardia [PDF]
Zhengyu Bao, Ye Zhu, Jia You
openalex +1 more source
Comparing methods of adenosine administration in paroxysmal supraventricular tachycardia: a pilot randomized controlled trial. [PDF]
Daengbubpha P+4 more
europepmc +1 more source
A study on the opportunity for paroxysmal supraventricular tachycardia treatment with radiofrequency catheter ablation: an insight from older patients with paroxysmal supraventricular tachycardia [PDF]
Wang Yu-chuan+7 more
openalex +1 more source
Class IV antiarrhythmic agents: new compounds using an old strategy [PDF]
Bányász, Tamás+5 more
core +1 more source
Background: Arrhythmias in patients with cancer are predominantly attributed to heart disease, anti-tumor drugs, and primary cardiac tumors. Arrhythmias directly induced by noncardiac primary tumors are rare. To date, there have been no reported cases of
Xiujing Yao+4 more
doaj
Update on Etripamil Nasal Spray for the At-home Treatment of Acute Paroxysmal Supraventricular Tachycardia. [PDF]
Chu GS, Gupta D.
europepmc +1 more source